

GEA Group's share has transformed from a late-cycle "quality industrial" trading in the high-20s to low-30s EUR five years ago into a higher-quality, cash-generative business now trading around 65.25 EUR. The story evolved from restructuring and margin repair into a steadier profitable compounder, punctuated by periodic macro-driven volatility.
Under CEO Stefan Klebert, GEA pushed portfolio streamlining, cost reductions and a sharper focus on core process technology and services. The stock traded in the high-20s to low-30s EUR in 2020 and began to rerate into the low-40s as investors priced in improving margins and a cleaner balance sheet with rising net liquidity.
Investor debate centered on whether margin gains and better capital discipline were sustainable or merely cyclical. COVID also made GEA look relatively resilient versus more cyclical industrial names—its exposure to food, beverage and pharma processing reinforced a defensive tilt in perception.
The five-year low sat around 27.4 EUR, with a push to the mid-40s as the market priced in successful restructuring. The chart featured a strong uptrend off 2020 lows, followed by consolidation in a 30–40 EUR band as investors waited for proof that earnings and cash flow improvements would stick.
GEA reported stable revenue (around mid-single-digit billions EUR) with EBITDA margins improving and earnings per share of 2.28 EUR, signaling the operational turnaround was gaining traction. Management emphasized service revenue growth, mix improvement and disciplined capital allocation, helping the market see the business as structurally more profitable.
Despite energy price spikes, supply-chain disruptions and European recession fears, GEA's food and pharma end-markets proved comparatively resilient. The stock began trading as a "defensive industrial compounder" rather than a high-beta cyclical. Valuation concerns and macro uncertainty kept the share from breaking out; year-end 2022 closed at 38.20 EUR, with an intrayear high of 48.52 EUR and low of 31.66 EUR.
The chart showed a wide sideways range between the low-30s and high-40s, with several failed breakout attempts above the mid-40s as risk-off sentiment hit European industrials. Pullbacks toward the low-30s held previous support, establishing a multi-year support zone that would be respected in 2023.
GEA delivered revenue of about 5.37 billion EUR with EBITDA before restructuring of 774 million EUR (14.4% margin) and earnings per share of 2.28 EUR, confirming the margin uplift. The company increased its dividend to 1.00 EUR per share with a 38% payout ratio, and investors began framing the stock as a steady cash generator rather than a fragile turnaround.
The narrative shifted toward "quality compounder at a reasonable price." GEA joined DAX and ESG indices, benefiting from demand for European sustainability-tilted industrials and its strong food and pharma positioning. Year-end 2023 closed at 37.69 EUR, with a high of 44.52 EUR and low of 31.69 EUR.
The repeated defense of the low-30s and a gradual series of higher lows created a medium-term ascending structure, even though price remained broadly range-bound below the mid-40s resistance.
GEA reported revenue of 5.42 billion EUR, organic growth of 3.7%, and EBITDA before restructuring of 837 million EUR (15.4% margin), marking another margin step-up, while free cash flow rose to 504.8 million EUR. Earnings per share increased to 2.30 EUR and the dividend was raised to 1.15 EUR per share with a 43% payout, reinforcing the image of a disciplined, shareholder-friendly industrial.
By December 31, 2024, the share closed at 47.82 EUR, up from 37.69 EUR a year earlier, with a 2024 intrayear high of 49.42 EUR and low of 35.19 EUR. The narrative pivoted decisively toward "defensive compounder with improving ESG profile," supported by net liquidity of 343.5 million EUR at year-end and strong ROCE of 33.8%.
Technically, 2024 marked a clear breakout: the stock pushed through the long-standing 40–45 EUR resistance band and sustained prices in the mid-40s to high-40s. Pullbacks toward the low-40s were bought, confirming this zone as new support and marking the start of a structural uptrend extending into 2025 and early 2026.
Through 2025, GEA shares continued to rerate as consensus estimates highlighted mid-teens P/E and solid dividend yield, with broker target price upgrades such as RBC's call to around the high-50s EUR. The company was praised for capital efficiency, financial health and sustained margin improvement, while investors increasingly framed it as a stable, ESG-aligned industrial rather than a restructuring story.
Price performance accelerated: by October 2025, the stock traded around the low-60s, with a 5-year high near 66.8 EUR underscoring the magnitude of the multi-year rerating. Over one year the stock delivered a strong positive return, and over the current year it was up about one-third.
Technically, the last 18–24 months form a strong uptrend: higher highs and higher lows from the mid-30s in 2023 to the mid-60s by early 2026, punctuated by consolidations in the 50–55 and then 60–65 EUR zones. The current price of 65.25 sits near the documented 5-year high around 66.8 EUR, putting GEA in a mature uptrend where investors watch for either continuation toward new highs or a consolidation phase after a substantial multi-year rerating.
GEA Group AG (G1A.XETRA) is a leading German provider of process technology, equipment, and solutions serving the global food, beverage, dairy, pharmaceutical, and related processing industries. It competes primarily against specialized industrial machinery and food-processing system manufacturers across Europe and globally. The company operates in overlapping end-markets—dairy, brewery, and pharma processing among them—where it faces competition from both diversified machinery makers and focused niche players. Its risk profile reflects the cyclical nature of capital spending in these core industries, alongside intense competitive pressure and exposure to regulatory and sustainability requirements that govern food and pharmaceutical production.
GEA Group AG (G1A.XETRA) is a leading German supplier of process technology and equipment serving the food, beverage, dairy, pharmaceutical, and broader process industries. It operates in a global market that's fragmented and competitive, facing off against large diversified industrials alongside specialized equipment makers with entrenched regional positions and long-standing customer ties. The business carries familiar industrial risks: customer capex tends to move with cycles, competition keeps margins under pressure, large projects carry execution risk, and regulatory and sustainability demands in its core markets keep shifting. GEA has scale and technological depth working in its favor—real competitive assets—but it remains tethered to macroeconomic swings, competitive intensity, and the regulatory currents flowing through its end markets.
| Company | Ticker |
|---|---|
| Alfa Laval AB | ALFA.ST |
| Krones AG | KRN.XETRA |
| JBT Corporation | JBT.NYSE |
| Marel hf. | MAREL.IC |
| Bucher Industries AG | BUCN.SWX |
| The Middleby Corporation | MIDD.NASDAQ |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial| Period | GEA GROUP | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +7.76% | +6.77% | +7.73% |
| 3M | +12.11% | +4.94% | +9.67% |
| 6M | +4.40% | -0.18% | -2.83% |
| 1Y | +23.42% | +10.59% | +7.15% |
| 3Y | +69.81% | +4.47% | -11.13% |
| 5Y | +154.05% | +74.12% | +65.53% |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHow the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 26.2 | 2.0 | 4.5 | 16.5 |
| 1Y ago | 22.8 | 1.7 | 3.8 | 15.6 |
| 3Y ago | 17.7 | 1.4 | 3.1 | 15.1 |
| 5Y ago | 55.9 | 1.2 | 2.8 | 7.6 |
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2025 | 1.15 EUR | 2.01% | 2.17% |
| 2024 | 1.00 EUR | 2.64% | |
| 2023 | 0.95 EUR | 2.20% | |
| 2022 | 0.90 EUR | 2.40% | |
| 2021 | 0.85 EUR | 2.33% | |
| 2020 | 0.43 EUR | 1.48% | |
| 2020 | 0.42 EUR | 2.00% | |
| 2019 | 0.85 EUR | 3.34% | |
| 2018 | 0.85 EUR | 2.46% | |
| 2017 | 0.80 EUR | 2.07% | |
| 2016 | 0.80 EUR | 1.90% | |
| 2015 | 0.70 EUR | 1.53% | |
| 2014 | 0.60 EUR | 1.86% | |
| 2013 | 0.55 EUR | 2.16% | |
| 2012 | 0.55 EUR | 2.24% |
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue | 5.42B | 5.37B | 5.16B | 4.70B | 4.64B |
| Operating income (EBIT) | 593.03M | 504.90M | 466.88M | 380.90M | 286.06M |
| Net income | 385.04M | 392.76M | 401.43M | 305.17M | 96.83M |
| Free cash flow | 473.01M | 305.21M | 265.53M | 552.15M | 617.63M |
| Total assets | 6.03B | 5.95B | 5.92B | 5.87B | 5.69B |
| Equity | 2.42B | 2.40B | 2.28B | 2.08B | 1.92B |
| Net debt | -326.14M | -367.19M | -329.97M | -499.66M | -245.21M |